Sec Form 13D Filing - LAME JOHN C filing for LCNB CORP (LCNB) - 2021-11-22

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

RULE 13d-2(a)

(Amendment No. 2)

 

 

LCNB Corp.

(Name of Issuer)

Common Stock, no par value

(Title of Class of Securities)

50181P100

(CUSIP Number)

John C. Lame

8805 Tamiami Trail N. #128

Naples, FL 34108

Telephone: (513) 235-6982

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

November 19, 2021

(Date of Event Which Requires Filing of This Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.  ☐

 

 

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


  1    

  NAME OF REPORTING PERSONS

  I.R.S. Identification Nos. of above persons (entities only).

 

  John C. Lame and Susan K. Lame Irrevocable Trust u/a dated May 18, 2018

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

  (a)  ☒        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  SOURCE OF FUNDS

 

  PF

  5  

  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

 

  ☐

  6  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Florida

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

     7     

  SOLE VOTING POWER

 

     8   

  SHARED VOTING POWER

 

  676,480 (1)

     9   

  SOLE DISPOSITIVE POWER

 

   10   

  SHARED DISPOSITIVE POWER

 

  676,480 (1)

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  676,480

12  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

  ☐

13  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  5.44% (2)

14  

  TYPE OF REPORTING PERSON

 

  OO

 

(1)

676,480 shares of common stock owned by the John C. Lame and Susan K. Lame Irrevocable Trust u/a dated May 18, 2018, a Florida trust, of which John C. Lame and Susan K. Lame serve as joint trustees and share voting and dispositive power with regard to the shares held by the trust.

(2)

Based upon 12,433,328 shares outstanding as of September 30, 2021, according to the information contained in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on November 3, 2021.

 

2


  1    

  NAME OF REPORTING PERSONS

  I.R.S. Identification Nos. of above persons (entities only).

 

  John C. Lame IRA

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

  (a)  ☒        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  SOURCE OF FUNDS

 

  PF

  5  

  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

 

  ☐

  6  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Florida

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

     7     

  SOLE VOTING POWER

 

  119,800 (1)

     8   

  SHARED VOTING POWER

 

     9   

  SOLE DISPOSITIVE POWER

 

  119,800 (1)

   10   

  SHARED DISPOSITIVE POWER

 

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  119,800 (1)

12  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

  ☐

13  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  .96% (2)

14  

  TYPE OF REPORTING PERSON

 

  OO

 

(1)

John C. Lame is the trustee of the John C. Lame IRA and in such capacity has the right to vote and dispose of the securities held by the IRA.

(2)

Based upon 12,433,328 shares outstanding as of September 30, 2021, according to the information contained in the Issuer’s Form 10-Q filed with the SEC on November 3, 2021.

 

3


  1    

  NAME OF REPORTING PERSONS

  I.R.S. Identification Nos. of above persons (entities only).

 

  John C. Lame Roth Contributory IRA

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

  (a)  ☒        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  SOURCE OF FUNDS

 

  PF

  5  

  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

 

  ☐

  6  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Florida

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

     7     

  SOLE VOTING POWER

 

  81,720 (1)

     8   

  SHARED VOTING POWER

 

     9   

  SOLE DISPOSITIVE POWER

 

  81,720 (1)

   10   

  SHARED DISPOSITIVE POWER

 

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  81,720 (1)

12  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

  ☐

13  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  .66% (2)

14  

  TYPE OF REPORTING PERSON

 

  IN

 

(1)

John C. Lame is the trustee of the John C. Lame Roth Contributory IRA and in such capacity has the right to vote and dispose of the securities held by the Roth IRA.

(2)

Based upon 12,433,328 shares outstanding as of September 30, 2021, according to the information contained in the Issuer’s Form 10-Q filed with the SEC on November 3, 2021.

 

4


  1    

  NAME OF REPORTING PERSONS

  I.R.S. Identification Nos. of above persons (entities only).

 

  Susan K. Lame Roth Contributory IRA

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

  (a)  ☒        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  SOURCE OF FUNDS

 

  PF

  5  

  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)

 

  ☐

  6  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  Florida

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

 

     7     

  SOLE VOTING POWER

 

  22,000 (1)

     8   

  SHARED VOTING POWER

 

     9   

  SOLE DISPOSITIVE POWER

 

  22,000 (1)

   10   

  SHARED DISPOSITIVE POWER

 

11    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  22,000 (1)

12  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

  ☐

13  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

  .18% (2)

14  

  TYPE OF REPORTING PERSON

 

  IN

 

(1)

Susan K. Lame is the trustee of the Susan K. Lame Roth Contributory IRA and in such capacity has the right to vote and dispose of the securities held by the Roth IRA.

(2)

Based upon 12,433,328 shares outstanding as of September 30, 2021, according to the information contained in the Issuer’s Form 10-Q filed with the SEC on November 3, 2021.

 

5


Item 1.

Security and Issuer

This Schedule 13D relates to shares of common stock, without par value, of LCNB Corp., an Ohio corporation (the “Issuer”). The Issuer’s principal executive office is located at 2 North Broadway, Lebanon, Ohio 45036.

 

Item 2.

Identity and Background

This Schedule 13D is jointly filed by John C. Lame and Susan K. Lame, Mr. Lame’s spouse, in their capacities as co-trustees of the John C. Lame and Susan K. Lame Irrevocable Trust u/a dated May 18, 2018 (the “Trust”); the John C. Lame IRA (the “IRA”); the John C. Lame Roth Contributory IRA (the “John Lame Roth IRA”); and the Susan K. Lame Roth Contributory IRA (the “Susan Lame Roth IRA”) (collectively, the “Reporting Persons”). Item 2 is amended by the filing of this Amendment No. 2 to add Susan K. Lame as a Reporting Person in her capacity as trustee of the Susan Lame Roth IRA.

Mr. Lame is a citizen of the United States and his principal occupation is Chief Executive Officer of Untapped, LLC, a limited liability company. The principal business of Untapped, LLC is life guidance and wealth coaching.

Ms. Lame is a citizen of the United States and her principal occupation is special projects manager, Untapped, LLC. The principal business of Untapped, LLC is life guidance and wealth coaching.

The Trust is an irrevocable trust established by John C. Lame and Susan K. Lame for estate planning purposes. The IRA, the John Lame Roth IRA and the Susan Lame Roth IRA are retirement accounts established by Mr. and Mrs. Lame.

The address of each Reporting Person for purposes of this filing is: 8805 Tamiami Trail N. #128, Naples, Florida 34108.

By virtue of these relationships and pursuant to the beneficial ownership rules of the SEC, the Reporting Persons may be deemed to be members of a group.

The Reporting Persons have not, during the past five years, (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting, or mandating activities subject to, federal or state securities laws or a finding of any violation with respect to such laws.

 

Item 3.

Source and Amount of Funds or Other Consideration

The Trust purchased shares of the Issuer’s common stock using Trust funds. Commencing August 2, 2021, some of the shares purchased by the Trust were purchased through a margin account with Charles Schwab & Co., Inc. Shares of the Issuer’s common stock held in the Trust margin account are held as collateral for repayment of the margin debt, and accordingly an indeterminate portion of the margin debt at any given point in time is attributable to the Issuer’s common stock held by the Trust. Shares of the Issuer’s common stock held directly by the Trust, IRA, the John Lame Roth IRA, and the Susan Lame Roth IRA were acquired directly by these reporting persons. Shares of the Issuer are listed on the Nasdaq Capital Market under the symbol “LCNB”.

 

Item 4.

Purpose of the Transaction

As specifically set forth herein, this Amendment No. 2 amends the Schedule 13D filed on July 30, 2021, as amended by the filing of Amendment No. 1 on October 21, 2021. This Amendment No. 2 is being filed to reflect a change in the percentage of outstanding shares of the Issuer held by the Reporting Persons resulting from the additional 135,000 shares acquired by the Reporting Persons through open-market purchases. The Reporting Persons’ beneficial ownership increased by 1.09% of the outstanding shares of the Issuer from that previously reported. As of the Schedule 13D Amendment No. 1 filing date, the Reporting Persons collectively owned 765,000 shares of the Issuer’s common stock, which represented 6.15% of the outstanding shares of the Issuer. The percentage of outstanding shares of the Issuer that the Reporting Persons’ holding represents has increased to 7.24%, causing the need to file this Amendment No. 2.    

 

6


The Reporting Persons reserve the right to purchase or otherwise acquire additional securities of the Issuer, or sell or otherwise dispose of any securities of the Issuer beneficially owned by them, in each case, in the open market or in privately negotiated transactions, to the extent deemed advisable in light of market conditions, subsequent developments affecting the Issuer and the general business and future prospects of the Issuer.

 

Item 5.

Interest in Securities of the Issuer

Item 5(a) – (b) is hereby amended as follows:

(a) – (b) According to the Issuer’s Form 10-Q filed with the SEC on November 3, 2021, there were 12,433,328 shares of the Issuer’s common stock outstanding on September 30, 2021.

The following list sets forth the aggregate number and percentage of outstanding shares of the Issuer’s common stock owned beneficially by each Reporting Person:

 

Name

   No. of Shares   Percent of Class

John C. Lame and Susan K. Lame Irrevocable Trust u/a dated May 18, 2018

   676,480(1)   5.44%

John C. Lame IRA

   119,800(2)   .96%

John C. Lame Roth IRA

   81,720(2)   .66%

Susan K. Lame Roth IRA

   22,000(3)   .18%

TOTAL

   900,000   7.24%

 

(1)

John C. Lame and Susan K. Lame are joint trustees and have shared investment and voting authority with respect to these shares.

(2)

John C. Lame has sole investment and voting authority with respect to these shares.

(3)

Susan K. Lame has sole investment and voting authority with respect to these shares.

(c) The Reporting Persons’ transactions in the Issuer’s common stock in the past 60 days consist of the following purchases.

The following open-market transactions were effected by the John Lame IRA during the past sixty (60) days:

 

Trade Date    Buy/Sell    Number
of Shares
   Price Per
Share

11/19/2021

   Buy    1300    $19.47

11/19/2021

   Buy    50    $19.48

11/19/2021

   Buy    1104    $19.49

11/19/2021

   Buy    1000    $19.50

11/19/2021

   Buy    1199    $19.55

11/19/2021

   Buy    24    $19.56

 

7


11/19/2021

   Buy    323    $19.60

11/19/2021

   Buy    1000    $19.61

11/19/2021

   Buy    1000    $19.63

11/19/2021

   Buy    1132    $19.66

11/19/2021

   Buy    1031    $19.67

11/19/2021

   Buy    354    $19.68

11/19/2021

   Buy    483    $19.69

11/19/2021

   Buy    2000    $19.73

11/19/2021

   Buy    1000    $19.76

11/19/2021

   Buy    250    $19.79

11/19/2021

   Buy    2500    $19.80

11/19/2021

   Buy    50    $19.84

11/19/2021

   Buy    1000    $19.85

11/19/2021

   Buy    1950    $19.87

11/19/2021

   Buy    1000    $19.94

11/19/2021

   Buy    550    $19.95

11/19/2021

   Buy    1100    $19.97

11/19/2021

   Buy    100    $19.98

11/18/2021

   Buy    1000    $18.25

11/18/2021

   Buy    50    $18.50

11/18/2021

   Buy    1000    $18.63

11/18/2021

   Buy    1730    $18.70

11/18/2021

   Buy    1080    $18.71

11/18/2021

   Buy    190    $18.72

11/18/2021

   Buy    1200    $18.90

11/18/2021

   Buy    52    $18.92

11/18/2021

   Buy    4    $18.93

11/18/2021

   Buy    1121    $18.94

11/18/2021

   Buy    437    $18.95

11/18/2021

   Buy    507    $18.96

11/18/2021

   Buy    100    $18.98

11/18/2021

   Buy    1055    $18.99

11/18/2021

   Buy    524    $19.00

11/18/2021

   Buy    1000    $19.04

11/18/2021

   Buy    1000    $19.06

11/18/2021

   Buy    1000    $19.07

11/18/2021

   Buy    100    $19.16

11/18/2021

   Buy    1052    $19.17

11/18/2021

   Buy    548    $19.18

11/18/2021

   Buy    678    $19.29

11/18/2021

   Buy    8    $19.33

11/18/2021

   Buy    5    $19.35

11/18/2021

   Buy    309    $19.38

 

8


11/18/2021

   Buy    3600    $19.41

11/18/2021

   Buy    9950    $19.45

11/18/2021

   Buy    120    $19.49

11/18/2021

   Buy    10880    $19.50

11/18/2021

   Buy    5    $19.60

11/18/2021

   Buy    3    $19.64

11/18/2021

   Buy    992    $19.67

11/18/2021

   Buy    738    $19.70

11/18/2021

   Buy    300    $19.73

11/18/2021

   Buy    41    $19.74

11/18/2021

   Buy    700    $19.82

11/18/2021

   Buy    221    $19.89

The following open-market transactions were effected by the John C. Lame Roth IRA during the past sixty (60) days:

 

Trade Date    Buy/Sell    Number
of Shares
   Price Per
Share

11/17/2021

   Buy    300    $17.93

11/17/2021

   Buy    200    $17.96

11/17/2021

   Buy    1769    $17.98

11/17/2021

   Buy    166    $18.00

11/17/2021

   Buy    25    $18.01

11/17/2021

   Buy    1473    $18.03

11/17/2021

   Buy    32    $18.04

11/17/2021

   Buy    3793    $18.05

11/17/2021

   Buy    1500    $18.06

11/17/2021

   Buy    5    $18.18

11/17/2021

   Buy    5    $18.20

11/17/2021

   Buy    1883    $18.23

11/17/2021

   Buy    2103    $18.24

11/17/2021

   Buy    6017    $18.25

11/17/2021

   Buy    3    $18.33

11/17/2021

   Buy    50    $18.34

11/17/2021

   Buy    185    $18.37

11/17/2021

   Buy    70    $18.44

11/17/2021

   Buy    697    $18.46

11/17/2021

   Buy    902    $18.47

11/17/2021

   Buy    1599    $18.48

11/17/2021

   Buy    5703    $18.50

11/17/2021

   Buy    5903    $18.54

11/17/2021

   Buy    74    $18.55

11/17/2021

   Buy    110    $18.60

11/17/2021

   Buy    795    $18.71

 

9


11/17/2021

     Buy        4589      $ 18.85  

11/17/2021

     Buy        7805      $ 18.92  

11/17/2021

     Buy        680      $ 18.94  

11/17/2021

     Buy        1901      $ 18.95  

11/17/2021

     Buy        571      $ 18.96  

11/17/2021

     Buy        2800      $ 18.98  

11/17/2021

     Buy        900      $ 18.99  

11/17/2021

     Buy        9792      $ 19.00  

11/17/2021

     Buy        2700      $ 19.02  

11/16/2021

     Buy        220      $ 17.94  

11/16/2021

     Buy        450      $ 17.96  

11/16/2021

     Buy        200      $ 17.97  

11/16/2021

     Buy        596      $ 17.98  

11/16/2021

     Buy        817      $ 17.99  

11/16/2021

     Buy        100      $ 18.06  

The following open-market transactions were effected by the Susan K. Lame Roth IRA during the past sixty (60) days:

 

Trade Date    Buy/Sell    Number
of Shares
   Price per
Share

11/17/2021

   Buy    1610    $18.60

11/17/2021

   Buy    10000    $18.95

11/17/2021

   Buy    280    $18.97

11/17/2021

   Buy    100    $18.79

11/17/2021

   Buy    10    $18.94

11/17/2021

   Buy    10000    $19.00

(d) No one other than the Reporting Persons has the right to receive or the power to direct the receipt of dividends or proceeds of sale of the shares.

(e) not applicable

 

Item 6.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Other than as described herein, there are no contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Persons and any person with respect to any securities of the Issuer, including, but not limited to, transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

 

10



SIGNATURES

After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: November 22, 2021

 

John C. Lame and Susan K. Lame Irrevocable Trust u/a dated May 18, 2018
By:  

/s/ John C. Lame

  John C. Lame, Co-Trustee
By:  

/s/ Susan K. Lame

  Susan K. Lame, Co-Trustee
John C. Lame IRA
By:  

/s/ John C. Lame

  John C. Lame
John C. Lame Roth Contributory IRA
By:  

/s/ John C. Lame

  John C. Lame
Susan K. Lame Roth Contributory IRA
By:  

/s/ Susan K. Lame

  Susan K. Lame

 

 

12